Copyright
©The Author(s) 2023.
World J Clin Cases. Aug 6, 2023; 11(22): 5204-5214
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5204
Published online Aug 6, 2023. doi: 10.12998/wjcc.v11.i22.5204
Age (yr) | 65.9 ± 12.8 (21-86) |
Sex (male/female) | 118/161 |
Genotype (1b/2a/2b/1a+2b/3a+3b/unknown) | 121/54/25/1/2/26 |
Interferon (yes/no/unknown) | 64/215/0 |
HCV RNA (LogIU/mL) | 5.87 ± 0.91 (2.3-7.3) |
ALT (IU/L) | 71.6 ± 216.6 (4-497) |
Total bilirubin (mg/dL) | 0.86 ± 0.90 (0.05-9.0) |
Alb (g/dL) | 4.15 ± 0.39 (2.70-5.25) |
WBC (104/mm3) | 5.10 ± 1.72 (2.0-12.2) |
Hb (g/dL) | 13.7 ± 1.70 (8.3-18.1) |
Plt (104/mm3) | 17.2 ± 6.30 (4.4-40.4) |
PT (%) | 99.7 ± 18.3 (11.5-154.3) |
AFP (ng/mL) | 8.46 ± 16.27 (0.6-140.5) |
Vs (m/s) | 1.55 ± 0.25 (1.03-2.62) |
Fib-4 index | 3.41 ± 2.89 (0.23-22.0) |
aMAP score | 58.7 ± 8.6 (27.4-76.7) |
Observation period (M) | 33.8 ± 26.2 (6-85) |
Hepatocellular carcinoma (Yes/No) | 12/267 |
- Citation: Masaoka R, Gyotoku Y, Shirahashi R, Suda T, Tamano M. Combining the age-male-albumin-bilirubin-platelets score and shear wave elastography stratifies carcinogenic risk in hepatitis C patients after viral clearance. World J Clin Cases 2023; 11(22): 5204-5214
- URL: https://www.wjgnet.com/2307-8960/full/v11/i22/5204.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i22.5204